🔗 Visit the ClinicalTrials.gov page for NCT00689702
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. | J Clin Oncol | 2001 | 1.87 |
| 2 | Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. | Int J Radiat Oncol Biol Phys | 2005 | 1.22 |
| 3 | Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. | Croat Med J | 2006 | 0.88 |
| 4 | Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial. | Radiol Oncol | 2012 | 0.85 |
| 5 | Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774). | Adv Exp Med Biol | 2003 | 0.78 |